Revolution Medicines, Warrant Stock Cash Flow From Operations

RVMDW Stock   0.32  0.08  20.00%   
Revolution Medicines, Warrant fundamentals help investors to digest information that contributes to Revolution Medicines,'s financial success or failures. It also enables traders to predict the movement of Revolution Stock. The fundamental analysis module provides a way to measure Revolution Medicines,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Revolution Medicines, stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Revolution Medicines, Warrant Company Cash Flow From Operations Analysis

Revolution Medicines,'s Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Operating Cash Flow

 = 

EBITDA

-

Taxes

More About Cash Flow From Operations | All Equity Analysis

Current Revolution Medicines, Cash Flow From Operations

    
  (350.57 M)  
Most of Revolution Medicines,'s fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Revolution Medicines, Warrant is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Revolution Cash Flow From Operations Driver Correlations

Understanding the fundamental principles of building solid financial models for Revolution Medicines, is extremely important. It helps to project a fair market value of Revolution Stock properly, considering its historical fundamentals such as Cash Flow From Operations. Since Revolution Medicines,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Revolution Medicines,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Revolution Medicines,'s interrelated accounts and indicators.
1.0-0.980.98-0.98-0.911.00.90.991.0-0.781.0-0.88-0.97-0.950.840.9
1.0-0.980.98-0.98-0.911.00.90.991.0-0.771.0-0.88-0.97-0.950.830.9
-0.98-0.98-0.950.990.83-0.98-0.93-0.98-0.980.81-0.980.840.950.9-0.91-0.91
0.980.98-0.95-0.93-0.940.970.840.950.98-0.630.98-0.87-1.0-0.990.750.9
-0.98-0.980.99-0.930.83-0.99-0.92-1.0-0.980.87-0.980.850.930.88-0.89-0.88
-0.91-0.910.83-0.940.83-0.89-0.64-0.86-0.910.52-0.910.950.920.93-0.59-0.71
1.01.0-0.980.97-0.99-0.890.911.01.0-0.811.0-0.87-0.96-0.930.860.89
0.90.9-0.930.84-0.92-0.640.910.910.9-0.80.9-0.61-0.86-0.820.90.95
0.990.99-0.980.95-1.0-0.861.00.910.99-0.850.99-0.86-0.94-0.90.870.88
1.01.0-0.980.98-0.98-0.911.00.90.99-0.761.0-0.88-0.98-0.950.820.9
-0.78-0.770.81-0.630.870.52-0.81-0.8-0.85-0.76-0.770.650.630.55-0.85-0.63
1.01.0-0.980.98-0.98-0.911.00.90.991.0-0.77-0.88-0.98-0.950.830.9
-0.88-0.880.84-0.870.850.95-0.87-0.61-0.86-0.880.65-0.880.840.81-0.68-0.6
-0.97-0.970.95-1.00.930.92-0.96-0.86-0.94-0.980.63-0.980.840.99-0.75-0.93
-0.95-0.950.9-0.990.880.93-0.93-0.82-0.9-0.950.55-0.950.810.99-0.67-0.91
0.840.83-0.910.75-0.89-0.590.860.90.870.82-0.850.83-0.68-0.75-0.670.8
0.90.9-0.910.9-0.88-0.710.890.950.880.9-0.630.9-0.6-0.93-0.910.8
Click cells to compare fundamentals
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Competition

In accordance with the recently published financial statements, Revolution Medicines, Warrant has (350.57 Million) in Cash Flow From Operations. This is 166.49% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 136.1% higher than that of the company.

Revolution Cash Flow From Operations Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Revolution Medicines,'s direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Revolution Medicines, could also be used in its relative valuation, which is a method of valuing Revolution Medicines, by comparing valuation metrics of similar companies.
Revolution Medicines, is currently under evaluation in cash flow from operations category among its peers.

Revolution Medicines, Current Valuation Drivers

We derive many important indicators used in calculating different scores of Revolution Medicines, from analyzing Revolution Medicines,'s financial statements. These drivers represent accounts that assess Revolution Medicines,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Revolution Medicines,'s important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap1.7B2.6B1.8B1.9B3.2B3.4B
Enterprise Value1.7B2.6B1.8B1.8B2.6B1.4B

Revolution Fundamentals

About Revolution Medicines, Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Revolution Medicines, Warrant's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revolution Medicines, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revolution Medicines, Warrant based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revolution Stock Analysis

When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.